Analyst Ratings for Abbott Labs (ABT)

Overall Rating: NEUTRAL Rating Trend:

Avg. $ Target: $47.00 (+28.7%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
5/21/2013	Gabelli	New Coverage	Buy (N/A)	47.00 (N/A)	37.81	36.53	-3.39%	Details
5/20/2013	Goldman Sachs	Upgrade	Buy (Neutral)	44.00 (38.00)	36.59	36.53	-0.16%	Details
4/12/2013	Credit Suisse	New Coverage	Neutral (N/A)	40.00 (N/A)	37.27	36.53	-1.99%	Details
2/15/2013	Stifel Nicolaus	New Coverage	Buy (N/A)	40.00 (N/A)	34.70	36.53	5.27%	Details
1/11/2013	Barclays	New Coverage	Equalweight (N/A)	35.00 (N/A)	33.85	36.53	7.92%	Details
1/4/2013	Deutsche Bank » Updated 4/12/2013	Downgrade	Hold (Buy)	35.00 (N/A)	33.27	36.53	9.8%	Details
1/2/2013	BMO Capital	New Coverage	Outperform (N/A)	36.00 (N/A)	64.42	36.53	-43.29%	Details
12/20/2012	William Blair	New Coverage	Outperform (N/A)	N/A (N/A)	65.34	36.53	-44.09%	Details
10/19/2012	Wells Fargo	Upgrade	Outperform (Market Perform)	72.50 (73.00)	66.64	36.53	-45.18%	Details
10/18/2012	Raymond James	Downgrade	Market Perform (Outperform)	N/A (N/A)	69.04	36.53	-47.09%	Details
9/18/2012	Leerink Swann	Downgrade	Market Perform (Outperform)	67.50 (70.00)	69.12	36.53	-47.15%	Details
1/3/2012	Morgan Stanley	Downgrade	Equalweight (N/A)	N/A (N/A)	56.42	36.53	-35.25%	Details
9/27/2011	JPMorgan	Downgrade	Neutral (N/A)	55.00 (N/A)	50.75	36.53	-28.02%	Details
9/20/2011	Jefferies » Updated 6/7/2013	New Coverage	Buy (N/A)	44.00 (46.00)	51.99	36.53	-29.74%	Details
8/24/2011	Morgan Keegan	Downgrade	Market Perform (N/A)	57.00 (N/A)	50.51	36.53	-27.68%	Details

Like ABT Ratings? Also take a look at BMY, JNJ, ABBV, BIIB